Total Payments
$18,132
2024 Payments
$3,092
Companies
42
Transactions
929
Medicare Patients
12,496
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$17,323 (95.5%)
Education$808.82 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,323 | 917 | 95.5% |
| Education | $808.82 | 12 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,673 | 189 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,700 | 106 | $0 (2024) |
| Janssen Biotech, Inc. | $1,419 | 61 | $0 (2024) |
| LEO Pharma Inc. | $1,243 | 85 | $0 (2024) |
| GENZYME CORPORATION | $1,220 | 57 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,145 | 52 | $0 (2024) |
| Amgen Inc. | $1,070 | 48 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $853.45 | 51 | $0 (2024) |
| DUSA Pharmaceuticals, Inc. | $833.11 | 3 | $0 (2019) |
| PFIZER INC. | $654.50 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,092 | 148 | ABBVIE INC. ($581.75) |
| 2023 | $3,154 | 150 | AbbVie Inc. ($654.62) |
| 2022 | $3,283 | 166 | ABBVIE INC. ($1,054) |
| 2021 | $1,185 | 70 | LEO Pharma Inc. ($357.34) |
| 2020 | $1,150 | 65 | AbbVie Inc. ($218.98) |
| 2019 | $2,021 | 120 | AbbVie, Inc. ($406.82) |
| 2018 | $2,003 | 118 | AbbVie, Inc. ($332.44) |
| 2017 | $2,243 | 92 | DUSA Pharmaceuticals, Inc. ($798.89) |
All Payment Transactions
929 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.80 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.26 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.76 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.24 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.66 | General |
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.50 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.26 | General |
| Category: Immunology | ||||||
| 11/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.86 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,362 | 8,342 | $1.2M | $513,645 |
| 2022 | 28 | 3,182 | 8,275 | $1.5M | $610,202 |
| 2021 | 29 | 3,148 | 8,183 | $1.4M | $606,671 |
| 2020 | 33 | 2,804 | 5,701 | $746,323 | $298,510 |
Total Patients
12,496
Total Services
30,501
Medicare Billing
$2.0M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 78 | 765 | $340,695 | $152,814 | 44.9% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 81 | 791 | $235,702 | $104,727 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 689 | $148,023 | $55,359 | 37.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 561 | 729 | $81,914 | $26,972 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 368 | 445 | $67,508 | $25,169 | 37.3% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 78 | 756 | $50,959 | $22,680 | 44.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 178 | 193 | $40,511 | $16,806 | 41.5% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 57 | 99 | $32,068 | $14,301 | 44.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 155 | 188 | $31,870 | $12,720 | 39.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 468 | 2,663 | $29,722 | $12,708 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $26,608 | $9,989 | 37.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 117 | 131 | $24,828 | $9,474 | 38.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 63 | 77 | $21,733 | $8,757 | 40.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 47 | 63 | $18,876 | $7,251 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 141 | 164 | $15,520 | $5,967 | 38.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 24 | $12,207 | $5,211 | 42.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 85 | 125 | $10,516 | $4,701 | 44.7% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 25 | 71 | $10,008 | $4,484 | 44.8% |
| 69100 | Biopsy of ear | Office | 2023 | 52 | 57 | $9,197 | $2,658 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,819 | $2,520 | 43.3% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 35 | 50 | $4,947 | $2,221 | 44.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 23 | $9,424 | $2,115 | 22.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 16 | 27 | $2,971 | $1,336 | 45.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 11 | 12 | $2,657 | $1,193 | 44.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 15 | $1,432 | $513.99 | 35.9% |
About Dr. David Devries, M.D
Dr. David Devries, M.D is a Dermatology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467561589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Devries, M.D has received a total of $18,132 in payments from pharmaceutical and medical device companies, with $3,092 received in 2024. These payments were reported across 929 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($17,323).
As a Medicare-enrolled provider, Devries has provided services to 12,496 Medicare beneficiaries, totaling 30,501 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Chapel Hill, NC
- Active Since 08/30/2006
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1467561589
Products in Payments
- DUPIXENT (Biological) $1,605
- RINVOQ (Biological) $1,414
- Otezla (Drug) $1,369
- COSENTYX (Biological) $1,175
- TREMFYA (Drug) $1,019
- SKYRIZI (Biological) $952.21
- Sotyktu (Drug) $853.45
- Levulan (Drug) $798.89
- ENSTILAR (Drug) $647.58
- Humira (Biological) $598.65
- ADBRY (Biological) $518.75
- COSENTYX (Drug) $471.24
- TALTZ (Drug) $395.78
- OPZELURA (Drug) $395.15
- EUCRISA (Drug) $388.16
- DUPIXENT DUPILUMAB INJECTION (Biological) $368.51
- ILUMYA (Biological) $348.11
- DUPIXENT (Drug) $307.76
- HUMIRA (Biological) $294.58
- Cimzia (Drug) $254.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chapel Hill
Stefan Weiss, Md, MD
Dermatology — Payments: $850,209
Dermatology $850,209
Christopher Sayed, Md, MD
Dermatology — Payments: $687,682
Dermatology $687,682
Dr. Sue Ellen Cox, M.d, M.D
Dermatology — Payments: $292,909
Dermatology $292,909
Donna Culton, Md, MD
Dermatology — Payments: $137,260
Dermatology $137,260
Dr. Chris Adigun, M.d, M.D
Dermatology — Payments: $129,211
Dermatology $129,211
Dr. Aida Lugo-Somolinos, Md, MD
Dermatology — Payments: $45,638
Dermatology $45,638